New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes

Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent an unmet clinical need whose prognosis is still dismal. Alterations of immune response play a prominent role in AML/MDS pathogenesis, revealing novel options for immunotherapy. Among immune system regulators, CD47, immune che...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallazzi, Marco, Ucciero, Maghalie Anais Marie, Faraci, Danilo Giuseppe, Mahmoud, Abdurraouf Mokhtar, Al Essa, Wael, Gaidano, Gianluca, Mouhssine, Samir, Crisà, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320300/
https://www.ncbi.nlm.nih.gov/pubmed/35886899
http://dx.doi.org/10.3390/ijms23147542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320300/
https://www.ncbi.nlm.nih.gov/pubmed/35886899
http://dx.doi.org/10.3390/ijms23147542

Ejemplares similares